drugset / Trial / NCT04618952

Effect of Calcium- D Supplement on Hypertension

NCT04618952

Phase 4 Completed 98 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Triple-blind randomized clinical trial was done on 98 hypertensive women of postmenopausal ages in 2019. The study was executed for 8 weeks with close follow up and , 24-hour Ambulatory blood pressure monitoring (ABPM) was used to record the initial and final blood pressures of all participants. Patients were randomized to calcium-D supplement and placebo

Timeline

Start
2019-01-01
Primary completion
2020-08-01
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium carbonate Other / unclassified 500 mg Oral
Comparator Cholecalciferol Other / unclassified 200 iu Oral

Indications